High-throughput screening of small molecules identifies hepcidin antagonistss

Molecular Pharmacology

Volumn 83, Issue 3, 2013, Pages 681-690

  Fung, Eileen ^a   Sugianto, Priscilla ^a   Hsu, Jason ^b   Damoiseaux, Robert ^a,b   Ganz, Tomas ^a   Nemeth, Elizabeta ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Pathology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENFOTIAMINE; FERROPORTIN; FURSULTIAMINE;

ARTICLE; BIOTINYLATION; CELL SURFACE; CONTROLLED STUDY; DRUG APPROVAL; DRUG EFFECT; ENDOCYTOSIS; FLOW CYTOMETRY; FOOD AND DRUG ADMINISTRATION; HIGH THROUGHPUT SCREENING; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; UBIQUITINATION; WESTERN BLOTTING;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CATION TRANSPORT PROTEINS; CELL LINE; ENDOCYTOSIS; FURSULTIAMIN; HEK293 CELLS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; IRON; IRON METABOLISM DISORDERS; MALE; MICE; MICE, INBRED C57BL; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; RECEPTORS, LDL; SMALL MOLECULE LIBRARIES; THIAMINE; UBIQUITINATION;

EID: 84874302553     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.083428     Document Type: Article

References (33)

1. Besson-Fournier C, Latour C, Kautz L, Bertrand J, Ganz T, Roth MP, and Coppin H (2012) Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling. Blood 120: 431-439.
2. Cartwright GE (1966) The anemia of chronic disorders. Semin Hematol 3:351-375.
3. Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, and Andrews NC (2005) The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 1:191-200. (Pubitemid 43960600)
4. Ehle M, Patel C, and Giugliano RP (2011) Digoxin: Clinical highlights: A review of digoxin and its use in contemporary medicine. Crit Pathw Cardiol 10:93-98.
5. Fernandes A, Preza GC, Phung Y, De Domenico I, Kaplan J, Ganz T, and Nemeth E (2009) The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood 114:437-443.
6. Finberg KE, Heeney MM, Campagna DR, Aydinok Y, Pearson HA, Hartman KR, Mayo MM, Samuel SM, Strouse JJ, and Markianos K et al. (2008) Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet 40:569-571. (Pubitemid 351601217)
7. Ganz T and Nemeth E (2011) Hepcidin and disorders of iron metabolism. Annu Rev Med 62:347-360.
8. Glaspy J (2012) Update on safety of ESAs in cancer-induced anemia. J Natl Compr Canc Netw 10:659-666.
9. Goodnough LT, Nemeth E, and Ganz T (2010) Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 116:4754-4761.
10. Hogle WP (2007) Cytoprotective agents used in the treatment of patients with cancer. Semin Oncol Nurs 23:213-224.
11. Kitamori N and Itokawa Y (1993) Pharmacokinetics of thiamin after oral administration of thiamin tetrahydrofurfuryl disulfide to humans. J Nutr Sci Vitaminol (Tokyo) 39:465-472. (Pubitemid 23357506)
12. Lonsdale D (2004) Thiamine tetrahydrofurfuryl disulfide: A little known therapeutic agent. Med Sci Monit 10:RA199-RA203. (Pubitemid 39278571)
13. Maes K, Nemeth E, Roodman GD, Huston A, Esteve F, Freytes C, Callander N, Katodritou E, Tussing-Humphreys L, and Rivera S et al. (2010) In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2. Blood 116:3635-3644.
14. Millea PJ (2009) N-acetylcysteine: Multiple clinical applications. Am Fam Physician 80:265-269.
15. Nemeth E, Preza GC, Jung CL, Kaplan J, Waring AJ, and Ganz T (2006) The Nterminus of hepcidin is essential for its interaction with ferroportin: Structurefunction study. Blood 107:328-333. (Pubitemid 43053559)
16. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, and Ganz T (2004a) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113:1271-1276. (Pubitemid 39069926)
17. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, and Kaplan J (2004b) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090-2093. (Pubitemid 40007660)
18. Nishikawa K, Kikuchi S, and Suzuoki Z (1970) The metabolic fate of methyl tetrahydrofurfuryl sulfide and its related compounds in rats. Eur J Pharmacol 9:111-115.
19. Pan X, Gong N, Zhao J, Yu Z, Gu F, Chen J, Sun X, Zhao L, Yu M, and Xu Z et al. (2010) Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice. Brain 133:1342-1351.
20. Preza GC, Ruchala P, Pinon R, Ramos E, Qiao B, Peralta MA, Sharma S, Waring A, Ganz T, and Nemeth E (2011) Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. J Clin Invest 121:4880-4888.
21. Qiao B, Sugianto P, Fung E, Del-Castillo-Rueda A, Moran-Jimenez MJ, Ganz T, and Nemeth E (2012) Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination. Cell Metab 15:918-924.
22. Riganti C, Campia I, Kopecka J, Gazzano E, Doublier S, Aldieri E, Bosia A, and Ghigo D (2011) Pleiotropic effects of cardioactive glycosides. Curr Med Chem 18:872-885.
23. Rivera S, Nemeth E, Gabayan V, Lopez MA, Farshidi D, and Ganz T (2005) Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood 106:2196-2199. (Pubitemid 41291740)
24. Roy CN, Mak HH, Akpan I, Losyev G, Zurakowski D, and Andrews NC (2007) Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood 109:4038-4044. (Pubitemid 46641759)
25. Sasu BJ, Cooke KS, Arvedson TL, Plewa C, Ellison AR, Sheng J, Winters A, Juan T, Li H, and Begley CG et al. (2010) Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. Blood 115:3616-3624.
26. Sham RL, Phatak PD, West C, Lee P, Andrews C, and Beutler E (2005) Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features. Blood Cells Mol Dis 34:157-161. (Pubitemid 40250491)
27. Takeda Kenkyusho Ho TAKHAA (1971) Journal of the Takeda Research Laboratories 30:242.
28. Theurl I, Schroll A, Sonnweber T, Nairz M, TheurlM,Willenbacher W, Eller K, Wolf D, Seifert M, and Sun CC et al. (2011) Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats. Blood 118:4977-4984.
29. Weiss G and Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352: 1011-1023.
30. Zaritsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, Ganz T, Rivera S, Nissenson AR, and Salusky IB (2009) Hepcidin-a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol 4:1051-1056.
31. Zelcer N, Hong C, Boyadjian R, and Tontonoz P (2009) LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 325:100-104.
32. Zhang JH, Chung TD, and Oldenburg KR (1999) A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 4:67-73. (Pubitemid 29278954)
33. Zhang Z, Zhang F, Guo X, An P, Tao Y, and Wang F (2012) Ferroportin1 in hepatocytes and macrophages is required for the efficient mobilization of body iron stores in mice. Hepatology 56:961-971.